Market Closed -
Bombay S.E.
06:00:51 2024-05-07 am EDT
|
5-day change
|
1st Jan Change
|
90.77
INR
|
-0.96%
|
|
-4.34%
|
-13.96%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
4,779
|
4,040
|
1,150
|
2,598
|
8,401
|
10,457
|
Enterprise Value (EV)
1 |
8,732
|
7,033
|
5,087
|
6,942
|
12,685
|
12,472
|
P/E ratio
|
15.9
x
|
5.66
x
|
2.58
x
|
8.92
x
|
6.26
x
|
2.89
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
1.02%
|
Capitalization / Revenue
|
0.46
x
|
0.34
x
|
0.11
x
|
0.26
x
|
0.55
x
|
0.45
x
|
EV / Revenue
|
0.83
x
|
0.58
x
|
0.49
x
|
0.69
x
|
0.83
x
|
0.54
x
|
EV / EBITDA
|
4.04
x
|
2.99
x
|
3.35
x
|
4.9
x
|
3.94
x
|
2.28
x
|
EV / FCF
|
21.7
x
|
113
x
|
-5.84
x
|
-94.2
x
|
-21.7
x
|
6.42
x
|
FCF Yield
|
4.61%
|
0.89%
|
-17.1%
|
-1.06%
|
-4.61%
|
15.6%
|
Price to Book
|
1.3
x
|
0.84
x
|
0.23
x
|
0.43
x
|
1.13
x
|
1
x
|
Nbr of stocks (in thousands)
|
91,816
|
96,649
|
96,649
|
107,130
|
107,090
|
107,090
|
Reference price
2 |
52.05
|
41.80
|
11.90
|
24.25
|
78.45
|
97.65
|
Announcement Date
|
12/1/18
|
9/5/19
|
9/3/20
|
9/3/21
|
8/22/22
|
9/6/23
|
Fiscal Period: Maart |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
10,462
|
12,046
|
10,403
|
10,087
|
15,253
|
23,257
|
EBITDA
1 |
2,164
|
2,348
|
1,518
|
1,417
|
3,222
|
5,473
|
EBIT
1 |
1,196
|
1,763
|
980.7
|
784.9
|
2,533
|
4,733
|
Operating Margin
|
11.43%
|
14.64%
|
9.43%
|
7.78%
|
16.6%
|
20.35%
|
Earnings before Tax (EBT)
1 |
734.9
|
1,052
|
647.9
|
488.7
|
2,094
|
4,421
|
Net income
1 |
296.1
|
684
|
472.7
|
289.5
|
1,342
|
3,616
|
Net margin
|
2.83%
|
5.68%
|
4.54%
|
2.87%
|
8.8%
|
15.55%
|
EPS
2 |
3.265
|
7.380
|
4.620
|
2.718
|
12.53
|
33.77
|
Free Cash Flow
1 |
402.2
|
62.26
|
-870.8
|
-73.72
|
-584.4
|
1,944
|
FCF margin
|
3.84%
|
0.52%
|
-8.37%
|
-0.73%
|
-3.83%
|
8.36%
|
FCF Conversion (EBITDA)
|
18.59%
|
2.65%
|
-
|
-
|
-
|
35.52%
|
FCF Conversion (Net income)
|
135.82%
|
9.1%
|
-
|
-
|
-
|
53.76%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
1.000
|
Announcement Date
|
12/1/18
|
9/5/19
|
9/3/20
|
9/3/21
|
8/22/22
|
9/6/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
3,953
|
2,993
|
3,937
|
4,344
|
4,284
|
2,014
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.827
x
|
1.275
x
|
2.593
x
|
3.066
x
|
1.329
x
|
0.368
x
|
Free Cash Flow
1 |
402
|
62.3
|
-871
|
-73.7
|
-584
|
1,944
|
ROE (net income / shareholders' equity)
|
13.8%
|
18.2%
|
9.46%
|
5.18%
|
19.9%
|
40.5%
|
ROA (Net income/ Total Assets)
|
6.89%
|
10.1%
|
5.17%
|
3.6%
|
10.4%
|
18%
|
Assets
1 |
4,296
|
6,785
|
9,140
|
8,049
|
12,929
|
20,054
|
Book Value Per Share
2 |
40.00
|
49.60
|
52.70
|
57.00
|
69.40
|
97.70
|
Cash Flow per Share
2 |
0.5300
|
0.7400
|
0.6600
|
3.030
|
1.390
|
1.880
|
Capex
1 |
806
|
893
|
1,571
|
1,252
|
1,378
|
1,710
|
Capex / Sales
|
7.7%
|
7.42%
|
15.1%
|
12.41%
|
9.04%
|
7.35%
|
Announcement Date
|
12/1/18
|
9/5/19
|
9/3/20
|
9/3/21
|
8/22/22
|
9/6/23
|
|
1st Jan change
|
Capi.
|
---|
| -13.96% | 118M | | +4.46% | 102B | | -3.35% | 65.27B | | +46.67% | 41.44B | | +19.71% | 40.05B | | +6.70% | 32.48B | | +11.78% | 19.71B | | +17.06% | 17.33B | | +20.73% | 15.6B | | +11.69% | 15.34B |
Other Commodity Chemicals
|